2013-04-01
Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q
Publication
Publication
Results from the Dutch named patient program
Leukemia and Lymphoma , Volume 54 - Issue 4 p. 874- 877
| Additional Metadata | |
|---|---|
| doi.org/10.3109/10428194.2012.728702, hdl.handle.net/1765/53920 | |
| Leukemia and Lymphoma | |
| Organisation | Erasmus School of Social and Behavioural Sciences |
|
Abouyahya, I., Alhan, C., Westers, T., te Boekhorst, P., Kappers-Klunne, M., Coenen, J., Heyning, F., Huls, G., de Wolf, J., Imholz, B., Koene, H., Veth, G., de Kruijf, E.-J. F., Muus, P., Planken, E., Segeren, C., Vasmel, W., van der Velden, A. M. T., Velders, F., … van de Loosdrecht, A. (2013). Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: Results from the Dutch named patient program. Leukemia and Lymphoma, 54(4), 874–877.https://doi.org/10.3109/10428194.2012.728702 |
|